Keyword: Par

News

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

05.03.2013 - Par Pharmaceutical has agreed to pay $45 million to settle federal criminal and civil probes over its marketing and sale of a drug to treat appetite loss in AIDS patients, a...

News

Watson Gets US Approval to Buy Actavis

16.10.2012 - Watson Pharmaceuticals has won U.S. antitrust approval to buy Swiss peer Actavis on the condition that it sell a number of their current and future products to two other companies...